trending Market Intelligence /marketintelligence/en/news-insights/trending/tA60RMeVxHmJcsb42nio5g2 content esgSubNav
In This List

Lansen Pharmaceutical buys 20% stake in Chinese company

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Lansen Pharmaceutical buys 20% stake in Chinese company

China's Lansen Pharmaceutical Holdings Ltd. said it bought a 20% stake in Tianjin Robustnique Biotechnology Co. Ltd., a producer of cosmetics and biological skincare products that also operates in the country.

Lansen Pharmaceutical, an investment holding company that develops, produces and sells specialty pharmaceuticals, paid 14 million Chinese yuan for the stake.

London-listed Cathay International Holdings Ltd., an investment holding company that invests in China's healthcare sector, owns a little over half of Lansen Pharmaceutical.

As of Dec. 28, US$1 was equivalent to 6.88 Chinese yuan.